Essex Investment Management CO LLC Novo Cure LTD Transaction History

Essex Investment Management CO LLC

$536 Million
Q3 2024

A detailed history of Essex Investment Management CO LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Essex Investment Management CO LLC holds 161,937 shares of NVCR stock, worth $2.68 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

161,937

Previous 161,486 0.28%

Holding current value

$2.68 Million

Previous $2.77 Million 8.5%

% of portfolio

0.47%

Previous 0.55%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$15.61 - $23.34 $7,040 - $10,526	451 Added 0.28%	161,937 $2.53 Million
Q2 2024 Aug 12, 2024	BUY	$11.83 - $24.05 $1.91 Million - $3.88 Million	161,486 New	161,486 $2.77 Million
Q3 2021 Nov 09, 2021	SELL	$116.17 - $194.55 $1.98 Million - $3.31 Million	-17,036 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $945,400 - $1.64 Million	-7,250 Reduced 29.85%	17,036 $3.78 Million
Q1 2021 May 12, 2021	BUY	$124.11 - $190.17 $370,716 - $568,037	2,987 Added 14.02%	24,286 $3.21 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $1.18 Million - $1.83 Million	-10,535 Reduced 33.09%	21,299 $3.69 Million
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $349,925 - $670,976	-6,028 Reduced 15.92%	31,834 $3.54 Million
Q2 2020 Aug 04, 2020	SELL	$57.2 - $74.41 $86,143 - $112,061	-1,506 Reduced 3.83%	37,862 $2.25 Million
Q1 2020 May 04, 2020	SELL	$57.05 - $95.75 $83,235 - $139,699	-1,459 Reduced 3.57%	39,368 $2.65 Million
Q4 2019 Feb 10, 2020	BUY	$68.3 - $93.8 $102,450 - $140,700	1,500 Added 3.81%	40,827 $3.44 Million
Q3 2019 Oct 22, 2019	SELL	$61.86 - $97.8 $908,908 - $1.44 Million	-14,693 Reduced 27.2%	39,327 $2.94 Million
Q2 2019 Aug 15, 2019	SELL	$42.22 - $63.23 $2.26 Million - $3.38 Million	-53,489 Reduced 49.75%	54,020 $3.42 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $1.19 Million - $2.09 Million	-37,159 Reduced 25.69%	107,509 $5.18 Million
Q4 2018 Feb 06, 2019	SELL	$28.72 - $52.63 $702,462 - $1.29 Million	-24,459 Reduced 14.46%	144,668 $4.84 Million
Q3 2018 Oct 16, 2018	BUY	$32.0 - $52.4 $145,600 - $238,420	4,550 Added 2.76%	169,127 $8.86 Million
Q2 2018 Jul 17, 2018	SELL	$19.85 - $32.0 $15,780 - $25,440	-795 Reduced 0.48%	164,577 $5.15 Million
Q1 2018 Apr 26, 2018	SELL	$19.3 - $23.65 $113,194 - $138,707	-5,865 Reduced 3.43%	165,372 $3.61 Million
Q4 2017 Feb 05, 2018	BUY	$16.3 - $21.9 $1.45 Million - $1.94 Million	88,753 Added 107.6%	171,237 $3.46 Million
Q3 2017 Oct 30, 2017	BUY	$18.05 - $21.75 $1.49 Million - $1.79 Million	82,484	82,484 $1.64 Million

Others Institutions Holding NVCR

# of Institutions

260

Shares Held

76.8M

Call Options Held

900K

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.74B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Account

Essex Investment Management CO LLC Novo Cure LTD Transaction History